Abstract
1. Daunorubicin reductase, an enzyme ubiquitous in all mammalian tissues tested, converts daunorubicin, a cancer chemotherapeutic antibiotic, to daunorubicinol. A method for the estimation of daunorubicinol and daunorubicin reductase is described.
2. Daunorubicin and daunorubicinol were quantitatively extracted from enzyme assay mixtures with 0·3 N HCl in 50% ethanol and then completely hydrolysed to their respective aglycones. The aglycones were extracted, concentrated into toluene, separated by silicic acid microcolumn chromatography, and estimated by spectrofluorimetry.
3. Compared to previous methods, this method is highly reproducible and sensitive.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alberts D. S., Bachur N. R., Holtzman J. L. The pharmacokinetics of daunomycin in man. Clin Pharmacol Ther. 1971 Jan-Feb;12(1):96–104. doi: 10.1002/cpt197112196. [DOI] [PubMed] [Google Scholar]
- BACHUR N. R., MASEK K., MELMON K. L., UDENFRIEND S. FATTY ACID AMIDES OF ETHANOLAMINE IN MAMMALIAN TISSUES. J Biol Chem. 1965 Mar;240:1019–1024. [PubMed] [Google Scholar]
- Bachur N. R., Cradock J. C. Daunomycin metabolism in rat tissue slices. J Pharmacol Exp Ther. 1970 Nov;175(2):331–337. [PubMed] [Google Scholar]
- Bachur N. R. Daunorubicinol, a major metabolite of daunorubicin: isolation from human urine and enzymatic reactions. J Pharmacol Exp Ther. 1971 Jun;177(3):573–578. [PubMed] [Google Scholar]
- Bachur N. R., Gee M. Daunorubicin metabolism by rat tissue preparations. J Pharmacol Exp Ther. 1971 Jun;177(3):567–572. [PubMed] [Google Scholar]
- Bachur N. R., Moore A. L., Bernstein J. G., Liu A. Tissue distribution and disposition of daunomycin (NCS-82151) in mice: fluorometric and isotopic methods. Cancer Chemother Rep. 1970 Apr;54(2):89–94. [PubMed] [Google Scholar]
- Bernard J., Jacquillat C., Boiron M., Najean Y., Seligmann M., Tanzer J., Weil M., Lortholary P. Essai de traitement des leucémies aiguës lymphoblastiques et myéloblastiques par un antibiotique nouveau: la rubidomycine (13,057 RP). Etude de 61 observations. Presse Med. 1967 Apr 22;75(19):951–955. [PubMed] [Google Scholar]